Where are Exelixis's Headquarters?

Exelixis's Headquarters are in 1851 Harbor Bay Parkway ,Alameda,California,United States

What is Exelixis's phone number?

Exelixis's phone number is +1 650-837-7000

What is Exelixis's stock symbol?

Exelixis's stock symbol is EXEL

What is Exelixis's official website?

Exelixis's official website is https://www.exelixis.com

What is Exelixis's Revenue?

Exelixis's revenue is $500M - 1B

What is Exelixis's NAICS code?

Exelixis's NAICS code is 424210

What is Exelixis's Industry?

Exelixis is in the industry of Biotechnology

Who is Exelixis's CEO?

Exelixis's CEO is George Scangos

Who is Exelixis's Chief Business Officer?

Exelixis's Chief Business Officer is Ron Hoffman

Exelixis

Q: Who is Exelixis's Executive Vice President And Chief Medical Officer?

Exelixis's Executive Vice President And Chief Medical Officer is Vicki Goodman

Get Full Access

Description

Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat advanced melanoma; and MINNEBRO, an oral non-steroidal selective blocker of the mineralocorticoid receptor for the treatment of hypertension in Japan. In addition, Exelixis, Inc. is developing XL092, an oral tyrosine kinase inhibitor that targets VEGF receptors, MET, AXL, MER, and other kinases implicated in growth and spread of cancer. Exelixis, Inc. has research collaborations and license agreements with Ipsen Pharma SAS; Takeda Pharmaceutical Company Ltd.; F. Hoffmann-La Roche Ltd.; Redwood Bioscience, Inc.; R.P. Scherer Technologies, LLC; Catalent Pharma Solutions, Inc.; NBE Therapeutics AG; Aurigene Discovery Technologies Limited; Iconic Therapeutics, Inc.; Invenra, Inc.; StemSynergy Therapeutics, Inc.; Genentech, Inc.; GlaxoSmithKline; Bristol-Myers Squibb Company; and Daiichi Sankyo Company, Limited. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was founded in 1994 and is headquartered in Alameda, California.
Headquarters:1851 Harbor Bay Parkway , Alameda, California, United States
More
Phone Number: +1 650-837-7000
Website: https://www.exelixis.com
Employees:863
Revenue:$500M - 1B
Legal Name:Exelixis
Exelixis's Social Media
Is this data correct?
| NAICS Code: 424210 |

NYSE: EXEL
Show More

CEO for Exelixis

George Scangos

Chief Executive Officer

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Ron Hoffman

Chief Business Officer

Vicki Goodman

Executive Vice President And Chief Medical Officer

Chris Senner

Executive Vice President And Chief Financial Officer

Peter Lamb

Chief Strategy Officer, Executive Vice President Discovery

Gisela Schwab